MEDICURE INC (MPH.CA) Stock Fundamental Analysis
Canada • TSX Venture Exchange • TSX-V:MPH • CA58469E4085
1.16 CAD
-0.07 (-5.69%)
Last: Jan 29, 2026, 07:00 PM
We assign a fundamental rating of 3 out of 10 to MPH. MPH was compared to 23 industry peers in the Biotechnology industry. MPH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MPH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- MPH had negative earnings in the past year.
- MPH had a positive operating cash flow in the past year.
- In the past 5 years MPH reported 4 times negative net income.
- Of the past 5 years MPH 4 years had a positive operating cash flow.
1.2 Ratios
- MPH has a Return On Assets of -12.83%. This is in the better half of the industry: MPH outperforms 78.26% of its industry peers.
- MPH's Return On Equity of -19.81% is fine compared to the rest of the industry. MPH outperforms 78.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.83% | ||
| ROE | -19.81% | ||
| ROIC | N/A |
ROA(3y)-0.74%
ROA(5y)-4.98%
ROE(3y)-1.05%
ROE(5y)-8.57%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MPH has a better Gross Margin (47.67%) than 78.26% of its industry peers.
- MPH's Gross Margin has been stable in the last couple of years.
- MPH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 47.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5Y-1.35%
2. Health
2.1 Basic Checks
- MPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, MPH has about the same amount of shares outstanding.
- MPH has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for MPH is higher compared to a year ago.
2.2 Solvency
- MPH has an Altman-Z score of -2.12. This is a bad value and indicates that MPH is not financially healthy and even has some risk of bankruptcy.
- MPH has a Altman-Z score of -2.12. This is in the better half of the industry: MPH outperforms 69.57% of its industry peers.
- MPH has a debt to FCF ratio of 0.79. This is a very positive value and a sign of high solvency as it would only need 0.79 years to pay back of all of its debts.
- MPH has a Debt to FCF ratio of 0.79. This is amongst the best in the industry. MPH outperforms 95.65% of its industry peers.
- MPH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of MPH (0.03) is better than 73.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.79 | ||
| Altman-Z | -2.12 |
ROIC/WACCN/A
WACC7.8%
2.3 Liquidity
- MPH has a Current Ratio of 1.44. This is a normal value and indicates that MPH is financially healthy and should not expect problems in meeting its short term obligations.
- MPH's Current ratio of 1.44 is in line compared to the rest of the industry. MPH outperforms 56.52% of its industry peers.
- A Quick Ratio of 1.00 indicates that MPH should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.00, MPH is in line with its industry, outperforming 52.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- The earnings per share for MPH have decreased strongly by -68.69% in the last year.
- Looking at the last year, MPH shows a very strong growth in Revenue. The Revenue has grown by 24.30%.
- The Revenue has been growing slightly by 1.66% on average over the past years.
EPS 1Y (TTM)-68.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-279.68%
Revenue 1Y (TTM)24.3%
Revenue growth 3Y0.25%
Revenue growth 5Y1.66%
Sales Q2Q%56.6%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for MPH. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 95.65% of the companies in the same industry are more expensive than MPH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.54 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for MPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MEDICURE INC / MPH.CA FAQ
Can you provide the ChartMill fundamental rating for MEDICURE INC?
ChartMill assigns a fundamental rating of 3 / 10 to MPH.CA.
What is the valuation status for MPH stock?
ChartMill assigns a valuation rating of 2 / 10 to MEDICURE INC (MPH.CA). This can be considered as Overvalued.
What is the profitability of MPH stock?
MEDICURE INC (MPH.CA) has a profitability rating of 3 / 10.